Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 9/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.35 |
| ▸ | UBE2M | P61081 | 1/20 | 0.34 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1871234 | 0.89 | ADORA1 (0.47) | ADORA1ADORA3DRD2ADORA2B | |
| SCHEMBL1875007 | 0.89 | ADORA1 (0.55) | ADORA1ADORA3DRD2ADORA2B | |
| SCHEMBL1865267 | 0.87 | ADORA1 (0.44) | ADORA1ADORA3DRD2ADORA2B | |
| SCHEMBL1866939 | 0.84 | ADORA1 (0.44) | ADORA1ADORA3ADORA2B | |
| SCHEMBL1864689 | 0.83 | ADORA1 (0.44) | ADORA1ADORA3ADORA2BMAPT | |
| SCHEMBL1870359 | 0.83 | ADORA1 (0.44) | ADORA1ADORA3ADORA2B | |
| SCHEMBL1871730 | 0.83 | ADORA1 (0.40) | ADORA1ADORA3DRD2ADORA2B | |
| SCHEMBL1861450 | 0.82 | ADORA1 (0.49) | ADORA1ADORA3ADORA2B | |
| SCHEMBL1870705 | 0.82 | ADORA1 (0.42) | ADORA1ADORA3ADORA2B | |
| SCHEMBL1866236 | 0.79 | ADORA1 (0.41) | ADORA1ADORA3ADORA2BMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2499142-A1 | SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS, ITS PREPARATION AND USES THEREOF | Advinus Therapeutics Limited (IN) | 2012-09-19 | — | — | EP | disclosed |
| WO-2011055391-A1 | SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS, ITS PREPARATION AND USES THEREOF | ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) | 2011-05-12 | — | — | WO | disclosed |